Seeing haemoglobin SC: Challenging the misperceptions

Area of Science:

• Hematology
• Genetics
• Clinical Medicine

Background:

• Sickle cell hemoglobin C (HbSC) disease is historically understudied.
• It has been incorrectly regarded as a mild variant of sickle cell disease.
• HbSC can lead to significant and progressive health complications.

Purpose of the Study:

• To highlight the underappreciated clinical severity of HbSC disease.
• To emphasize the need for prospective research into HbSC complications.
• To address existing treatment gaps for patients with HbSC disease.

Main Methods:

• This is a commentary on a study by Nelson et al. published in Br J Haematol.
• The commentary reviews the clinical spectrum of HbSC disease.
• It synthesizes current understanding and identifies research needs.

Main Results:

• HbSC disease is associated with substantial and progressive complications.
• The condition is not a benign form of sickle cell disease.
• Significant treatment gaps exist for managing HbSC complications.

Conclusions:

• HbSC disease requires greater clinical attention due to its potential for severe complications.
• Prospective studies are essential to develop targeted therapies.
• Reclassifying HbSC as a non-benign condition is critical for patient care.